United States Antimony Corporation announced the addition of Michael A. McManus, age 80, as an Independent Director to its board. Michael McManus is a recognized leader and builder of enterprises with successes as a public company CEO, senior government experience, a lawyer, new product development leader, and since 1998 a Board member for Novavax, a biotechnology company committed to help address serious infectious diseases globally through the discovery, development, and delivery of innovative vaccines to patients around the world. Mr. McManus has previously served as president, chief executive officer, and director at Misonix Inc., a medical, scientific, and industrial provider of ultrasonic and air pollution systems, since 1998.

Prior to that tenure, he was president and chief executive officer at New York Bancorp Inc. from 1991 to 1998. From 1990 through November 1991, Mr. McManus was president and chief executive officer at Jamcor Pharmaceuticals Inc. Previously, Mr. McManus served as an assistant to the President of the United States from 1982 to 1985 and held positions with Pfizer Inc. and Revlon Group. Mr. McManus received a BA in economics from the University of Notre Dame and a JD from the Georgetown University Law Center.

He served in the US Army Infantry from 1968 through 1970. He is also a recipient of the Ellis Island Medal of Honor. Mr. McManus will stand for re-election at the next annual meeting of stockholders.